HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Use of conivaptan for management of hyponatremia following surgery for Cushing's disease.

AbstractBACKGROUND:
Hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common osmoregulatory complication following surgery for Cushing's disease. Conventional management includes water restriction and sodium repletion, however this regimen does not address the underlying pathophysiology of excessive vasopressin production. Vaptans are arginine vasopressin receptor antagonists shown to be effective in correcting water excess in other disease states of euvolemic and hypervolemic hyponatremia. The use of these agents has not been reported in Cushing's patients.
METHODS:
We retrospectively studied Cushing's patients at our institution with post-surgical hyponatremia (Na<130mEq/L) treated with and without conivaptan between 2005 and 2011. We report rates of serum sodium normalization and compare length-of-stay (LOS) between the groups.
RESULTS:
Hyponatremia developed in six of 98 patients (6.1%) undergoing resection of ACTH-positive pituitary adenomas. Three patients received conivaptan and fluid restriction±sodium supplementation, and three received conventional therapy alone. The rate of serum sodium normalization with conivaptan was 5.8±2.3mEq/L/20mg IV bolus given every 24h. All patients receiving conivaptan were discharged with normal serum sodium values and no instances of rapid overcorrection occurred. A trend toward longer LOS occurred in patients treated with conivaptan (4.6±0.3 days, mean±SE) versus conventional therapy alone (1.6±0.3 days).
CONCLUSIONS:
Conivaptan is a potentially useful treatment option for hyponatremia in the setting of Cushing's disease patients after pituitary surgery.
AuthorsJonathan D Breshears, Bowen Jiang, Nathan C Rowland, Sandeep Kunwar, Lewis S Blevins
JournalClinical neurology and neurosurgery (Clin Neurol Neurosurg) Vol. 115 Issue 11 Pg. 2358-61 (Nov 2013) ISSN: 1872-6968 [Electronic] Netherlands
PMID24041963 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines
  • conivaptan
  • Sodium
Topics
  • Adult
  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines (administration & dosage, therapeutic use)
  • Cushing Syndrome (complications, drug therapy, surgery)
  • Female
  • Humans
  • Hyponatremia (drug therapy, etiology)
  • Inappropriate ADH Syndrome (blood, complications, drug therapy)
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Pituitary Neoplasms (complications, surgery)
  • Retrospective Studies
  • Sodium (metabolism)
  • Water Deprivation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: